Universal Screening at Age 1–2 Years as an Adjunct to Cascade Testing for Familial Hypercholesterolaemia in the UK: A Cost-Utility Analysis

Atherosclerosis - Netherlands
doi 10.1016/j.atherosclerosis.2018.05.047